Elan Corporation PLC Sues as Biogen, Inc. (JOBS) Seeks Control Over Tysabri

Reuters -- Irish drugmaker Elan Corp PLC said on Thursday it has filed suit against Biogen Idec Inc in a bid to block Biogen from gaining control of the multiple sclerosis drug Tysabri.